WW International Inc
WW27.720USD
-2.400-7.97%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
276.84MMarket Cap
0.26P/E TTM
More Details of WW International Inc Company
WW International, Inc. provides science-backed weight loss and weight management programs. The Company provides an accessible, holistic model of care through its doctor-recommended Points Program, clinical interventions including weight-loss medications, and community support. Its weight-loss and weight management programs are focused on nutritional and behavior change science. They are comprised of a range of science-based nutritional, activity, behavioral and lifestyle tools and approaches that can be tailored for individual weight goals and, if needed, support the various needs of people taking GLP-1 medications. Its offerings include Behavior Change Programs, WeightWatchers Clinic, Licensing and Consumer Product Sales. Its subscription businesses include digital business, workshops + digital business, clinical business and WeightWatchers for business offering nutritional and behavior change science. Its WW-branded products include bars, snacks, cookbooks and kitchen tools.
WW International Inc Info
Ticker SymbolWW
Company nameWW International Inc
IPO dateNov 15, 2001
CEOComonte (Tara)
Number of employees3700
Security typeOrdinary Share
Fiscal year-endNov 15
Address18 West 18Th Street
CityNEW YORK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code10011
Phone12125892700
Websitehttps://www.weightwatchers.com/us/
Ticker SymbolWW
IPO dateNov 15, 2001
CEOComonte (Tara)
Company Executives of WW International Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Michael Amsel
Mr. Michael Amsel
Chief Marketing Officer
Chief Marketing Officer
3.43K
--
Ms. Uta Knablein
Ms. Uta Knablein
Chief Product Officer
Chief Product Officer
--
--
Ms. Jacquie Cooke
Ms. Jacquie Cooke
Chief Legal and Administrative Officer and Secretary
Chief Legal and Administrative Officer and Secretary
--
--
Ms. Felicia Dellafortuna
Ms. Felicia Dellafortuna
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Julie Bornstein
Ms. Julie Bornstein
Independent Director
Independent Director
--
--
Dr. Fallon O'Connor-Brooks
Dr. Fallon O'Connor-Brooks
Independent Director
Independent Director
--
--
Mr. John Mills
Mr. John Mills
IR Contact Officer
IR Contact Officer
--
--
Ms. Tara Comonte
Ms. Tara Comonte
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Nikolaj H. Sjoqvist
Mr. Nikolaj H. Sjoqvist
Independent Director
Independent Director
--
--
Mr. Eugene Irwin (Gene) Davis, J.D.
Mr. Eugene Irwin (Gene) Davis, J.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Michael Amsel
Mr. Michael Amsel
Chief Marketing Officer
Chief Marketing Officer
3.43K
--
Ms. Uta Knablein
Ms. Uta Knablein
Chief Product Officer
Chief Product Officer
--
--
Ms. Jacquie Cooke
Ms. Jacquie Cooke
Chief Legal and Administrative Officer and Secretary
Chief Legal and Administrative Officer and Secretary
--
--
Ms. Felicia Dellafortuna
Ms. Felicia Dellafortuna
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Julie Bornstein
Ms. Julie Bornstein
Independent Director
Independent Director
--
--
Dr. Fallon O'Connor-Brooks
Dr. Fallon O'Connor-Brooks
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Behavioral Subscription Revenues
157.26M
83.13%
Clinical Subscription Revenues
30.59M
16.17%
Product Sales And Other
1.31M
0.69%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Behavioral Subscription Revenues
157.26M
83.13%
Clinical Subscription Revenues
30.59M
16.17%
Product Sales And Other
1.31M
0.69%
Shareholding Stats
Updated: Sat, Nov 22
Updated: Sat, Nov 22
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Aristeia Capital, L.L.C.
9.01%
Carronade Capital Management LP
4.47%
JPMorgan Private Bank (United States)
3.82%
Contrarius Investment Management Ltd.
3.77%
Balyasny Asset Management LP
2.98%
Other
75.95%
Shareholders
Shareholders
Proportion
Aristeia Capital, L.L.C.
9.01%
Carronade Capital Management LP
4.47%
JPMorgan Private Bank (United States)
3.82%
Contrarius Investment Management Ltd.
3.77%
Balyasny Asset Management LP
2.98%
Other
75.95%
Shareholder Types
Shareholders
Proportion
Hedge Fund
24.44%
Investment Advisor
17.21%
Investment Advisor/Hedge Fund
11.88%
Bank and Trust
3.91%
Research Firm
2.51%
Pension Fund
0.55%
Individual Investor
0.33%
Family Office
0.20%
Holding Company
0.09%
Other
38.87%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
41
3.62M
36.25%
+974.95K
2025Q2
438
20.10M
24.64%
-32.99M
2025Q1
458
16.66M
20.68%
-36.51M
2024Q4
499
19.89M
24.83%
-54.79M
2024Q3
507
25.03M
31.39%
-59.37M
2024Q2
538
34.23M
43.18%
-58.37M
2024Q1
551
46.66M
58.89%
-51.69M
2023Q4
557
67.86M
85.74%
-30.15M
2023Q3
550
65.35M
82.74%
-28.31M
2023Q2
560
59.72M
75.99%
-24.95M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Aristeia Capital, L.L.C.
1.40M
13.97%
--
--
Jul 07, 2025
Aegon Asset Management US
110.15K
1.1%
--
--
Aug 31, 2025
Millennium Management LLC
437.59K
4.38%
+437.59K
--
Aug 04, 2025
Arini Capital Management Limited
278.89K
2.79%
-360.61K
-56.39%
Jul 07, 2025
Invesco Advisers, Inc.
69.68K
0.7%
-13.88K
-16.61%
Aug 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Acquirers Small and Micro Deep Value ETF
1.11%
Acquirers Small and Micro Deep Value ETF
Proportion1.11%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of WW International Inc?
The top five shareholders of WW International Inc are:
Aristeia Capital, L.L.C. holds 1.40M shares, accounting for 13.97% of the total shares.
Aegon Asset Management US holds 110.15K shares, accounting for 1.10% of the total shares.
Millennium Management LLC holds 437.59K shares, accounting for 4.38% of the total shares.
Arini Capital Management Limited holds 278.89K shares, accounting for 2.79% of the total shares.
Invesco Advisers, Inc. holds 69.68K shares, accounting for 0.70% of the total shares.
Aristeia Capital, L.L.C. holds 1.40M shares, accounting for 13.97% of the total shares.
Aegon Asset Management US holds 110.15K shares, accounting for 1.10% of the total shares.
Millennium Management LLC holds 437.59K shares, accounting for 4.38% of the total shares.
Arini Capital Management Limited holds 278.89K shares, accounting for 2.79% of the total shares.
Invesco Advisers, Inc. holds 69.68K shares, accounting for 0.70% of the total shares.
What are the top three shareholder types of WW International Inc?
The top three shareholder types of WW International Inc are:
Aristeia Capital, L.L.C.
Carronade Capital Management LP
JPMorgan Private Bank (United States)
Aristeia Capital, L.L.C.
Carronade Capital Management LP
JPMorgan Private Bank (United States)
How many institutions hold shares of WW International Inc (WW)?
As of 2025Q3, 41 institutions hold shares of WW International Inc, with a combined market value of approximately 3.62M, accounting for 36.25% of the total shares. Compared to 2025Q2, institutional shareholding has increased by 11.61%.
What is the biggest source of revenue for WW International Inc?
In FY2025Q2, the Behavioral Subscription Revenues business generated the highest revenue for WW International Inc, amounting to 157.26M and accounting for 83.13% of total revenue.
